Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0N1PT
|
||||
Former ID |
DNC005882
|
||||
Drug Name |
2-(4-chloro-1H-benzo[d]imidazol-2-yl)quinoxaline
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [527933] | ||
Structure |
Download2D MOL |
||||
Formula |
C15H9ClN4
|
||||
Canonical SMILES |
C1=CC=C2C(=C1)N=CC(=N2)C3=NC4=C(N3)C=CC=C4Cl
|
||||
InChI |
1S/C15H9ClN4/c16-9-4-3-7-12-14(9)20-15(19-12)13-8-17-10-5-1-2-6-11(10)18-13/h1-8H,(H,19,20)
|
||||
InChIKey |
KBVMQLRZERGALQ-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Adenosine A3 receptor | Target Info | Inhibitor | [527933] | |
Adenosine A1 receptor | Target Info | Inhibitor | [527933] | ||
NetPath Pathway | TCR Signaling Pathway | ||||
RANKL Signaling Pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.